Valuation: Divi's Laboratories Limited

Market Cap 2,139B 22.4B 19.48B 18.13B 16.64B 31.43B 31.92B 214B 83.86B 1,065B 84.14B 82.29B 3,570B P/E 2027 *
71.5x
P/E 2028 * 58.3x
Enterprise Value 2,105B 22.05B 19.17B 17.84B 16.38B 30.94B 31.42B 210B 82.55B 1,048B 82.82B 81B 3,514B EV / Sales 2027 *
16.7x
EV / Sales 2028 * 14.4x
Free-Float
48%
Yield 2027 *
0.44%
Yield 2028 * 0.5%
1 day+2.82%
1 week+11.14%
1 month+23.08%
3 months+23.89%
6 months+33.03%
Current year+26.02%
1 week 7,220.5
Extreme 7220.5
8,090
1 month 6,685.5
Extreme 6685.5
8,090
Current year 5,647.5
Extreme 5647.5
8,090
1 year 5,636.5
Extreme 5636.5
8,090
3 years 3,295.3
Extreme 3295.3
8,090
5 years 2,730
Extreme 2730
8,090
10 years 532.65
Extreme 532.65
8,090
Manager TitleAgeSince
Chief Executive Officer 75 25/11/2009
Chief Executive Officer 48 03/01/2020
Director of Finance/CFO 65 31/07/2025
Director TitleAgeSince
Director/Board Member 48 25/11/2009
Chairman 75 25/11/2009
Director/Board Member 68 01/10/1994
Date Insider Type Main position Quantity % Market Cap.
26/03/25 Sell

Executive/Senior Manager

25,000 0.0094%
15/03/25 Sell 300 0.0001%
17/02/25 Sell 500 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
+2.82%+11.14%+26.64%+121.35% 22.4B
-0.53%-3.95%+50.70%+153.56% 1,024B
+0.21%-2.68%+53.20%+51.79% 618B
-2.51%-3.25%+28.54%+68.94% 443B
+0.06%-0.42%+37.53%+30.67% 349B
-0.69%-0.30%+13.76%+12.83% 264B
-7.37%-4.40%-0.74%-44.28% 209B
-0.64%+2.43%+29.74%+65.93% 208B
-0.82%+0.70%+15.05%+72.05% 162B
+0.40%+1.92%+6.47%-29.77% 143B
Average -0.91%+0.02%+26.09%+50.31% 344.13B
Weighted average by Cap. -0.98%-1.93%+36.08%+72.22%

Financials

2027 *2028 *
Net sales 126B 1.32B 1.15B 1.07B 984M 1.86B 1.89B 12.63B 4.96B 62.93B 4.97B 4.86B 211B 146B 1.53B 1.33B 1.23B 1.13B 2.14B 2.17B 14.56B 5.71B 72.53B 5.73B 5.61B 243B
Net income 30.35B 318M 276M 257M 236M 446M 453M 3.03B 1.19B 15.11B 1.19B 1.17B 50.66B 37.18B 390M 339M 315M 289M 546M 555M 3.72B 1.46B 18.51B 1.46B 1.43B 62.07B
Net Debt -33.5B -351M -305M -284M -261M -492M -500M -3.35B -1.31B -16.68B -1.32B -1.29B -55.92B -42.14B -441M -384M -357M -328M -619M -629M -4.21B -1.65B -20.98B -1.66B -1.62B -70.34B
Logo Divi's Laboratories Limited
Divi's Laboratories Limited is specialized in the development and manufacture of active pharmaceutical ingredients, intermediates and nutraceutical ingredients. Net sales by source of revenue break down into product sales (97.9%) and service sales (2.1%). At the end of March 2020, the group has 2 production sites located in India.
Employees
11,565
Date Price Change Volume
31/07/26 ₹8,056.00 +2.82% 793,919
30/07/26 ₹7,835.00 +0.65% 651,446
29/07/26 ₹7,784.50 +4.84% 1,158,131
28/07/26 ₹7,425.00 +0.15% 410,385
27/07/26 ₹7,414.00 +2.28% 544,701
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
8,056.00INR
Average target price
7,198.80INR
Spread / Average Target
-10.64%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. DIVISLAB Stock